IBB ETF holdings (NASDAQ) - Page 4 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

ERAS Erasca, Inc. 22.4 M 1.4 M 0.3%

TARS Tarsus Pharmaceuticals, Inc. 20.9 M 297.5 K 0.3%

TWST Twist Bioscience Corp. 20.8 M 436.8 K 0.3%

C

CNTA Centessa Pharmaceuticals plc 20.7 M 520.8 K 0.3%

IDYA Ideaya Biosciences, Inc. 20.5 M 615.6 K 0.3%

DNLI Denali Therapeutics, Inc. 20.3 M 1.1 M 0.2%

TVTX Travere Therapeutics, Inc. 20.0 M 674.6 K 0.2%

IBRX ImmunityBio, Inc. 19.7 M 2.6 M 0.2%

ARQT Arcutis Biotherapeutics, Inc. 19.2 M 814.8 K 0.2%

VCYT Veracyte, Inc. 18.7 M 579.3 K 0.2%

GPCR Structure Therapeutics, Inc. 18.4 M 381.7 K 0.2%

EWTX Edgewise Therapeutics, Inc. 18.0 M 572.2 K 0.2%

TXG 10X Genomics, Inc. 17.9 M 841.7 K 0.2%

LEGN Legend Biotech Corp. 17.8 M 983.9 K 0.2%

NAMS Newamsterdam Pharma Co. NV 17.2 M 537.8 K 0.2%

VERA Vera Therapeutics, Inc. 16.9 M 419.8 K 0.2%

DYN Dyne Therapeutics, Inc. 16.6 M 917.5 K 0.2%

BEAM Beam Therapeutics, Inc. 16.5 M 692.1 K 0.2%

BCRX BioCryst Pharmaceuticals, Inc. 16.3 M 1.7 M 0.2%

KOD Kodiak Sciences, Inc. 16.1 M 422.4 K 0.2%

1
2
3
4
5
6
7
8
...
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026